Weather events such as extreme temperatures and drought caused global agricultural losses of 11.4 billion dollars in 2011, while 12 million hectares of farmland are lost to land degradation every year, and unsustainable agricultural practices contribute to the emission of greenhouse gases. These and other data provided by a report released Wednesday in London by leading scientists from 13 countries raise the question of how to curb the environmental crisis, guarantee...

This month, two women’s stories, told courageously, helped to underline the reality of domestic violence in India. Nita Bhalla, a journalist, wrote for the BBC about being physically assaulted by her partner. Meena Kandasamy, a poet and writer on social issues, wrote movingly in Outlook, a national newsmagazine, of surviving a violent marriage: “My skin has seen enough hurt to tell its own story.” Both Ms. Kandasamy and Ms. Bhalla are,...

The Supreme Court has handed down an extraordinary decision with some extraordinary arguments directing the central government to execute the “river interlinking project”. How could the Court which says “it can hardly take unto itself tasks of making of a policy decision or planning for the country on the need for acquisition and construction of river linking channels” then go on to actually take the very same policy decision and...

-The Times of India   In a bid to induce a fresh life into the ailing health services delivery system in Uttar Pradesh, the World Bank has signed a $152 million deal with the Central and UP governments. The funds will be used to finance the government's efforts to improve the efficiency, quality, and accountability of health services in the state. The project, called the Uttar Pradesh Health Systems Strengthening Project (UPHSSP) for...

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...